UROTHELIAL BLADDER CANCER

Clinical trials for UROTHELIAL BLADDER CANCER explained in plain language.

Never miss a new study

Get alerted when new UROTHELIAL BLADDER CANCER trials appear

Sign up with your email to follow new studies for UROTHELIAL BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2 Terminated 3

New Bladder-Sparing combo aims to avoid surgery in cancer patients

Disease control Not yet recruiting

This phase 2 trial tests whether a combination of two drugs—enfortumab vedotin (Padcev) and pembrolizumab (Keytruda)—can help people with muscle-invasive bladder cancer avoid bladder removal. About 56 participants will receive the drugs first, and those who respond well may get r…

Matched conditions: UROTHELIAL BLADDER CANCER

Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

UROTHELIAL BLADDER CANCER

Get alerted when new UROTHELIAL BLADDER CANCER trials appear

New Bladder-Sparing combo aims to avoid surgery in cancer patients